Karo Healthcare Buys Dermatologist-Approved Skincare Brand E45 From Reckitt Benckiser

 

Karo Healthcare, a leading Swedish healthcare company, has recently announced its acquisition of the esteemed 70-year-old dermatologist-approved skincare brand, E45, from Reckitt Benckiser.

 Recognised for its effective and clinically proven formulations, this £200 million acquisition represents a significant milestone for Karo Healthcare, reaffirming its steadfast commitment to providing top-tier skincare solutions to consumers worldwide.

In line with the strategic objectives of this acquisition, Karo Healthcare has appointed Ekulo International as its exclusive distributor, ensuring the availability of authentic E45 products in

Nigeria. This strategic partnership underscores Karo Healthcare's unwavering dedication to authenticity and excellence, pledging consumers access to dermatologist-approved skincare solutions that prioritise skin health and overall well-being.

Michael Smeets, the Head of Global Business Development at Karo, emphasised the profound importance of this collaboration in combating counterfeit products and ensuring Nigerians have access to skincare solutions with a global reputation for trust and efficacy. He stated, "If the E45 product does not bear the Karo name and address on the packaging, it should be regarded as counterfeit."

With this latest development, consumers can anticipate finding genuine E45 products proudly displaying the Karo Healthcare name and address, guaranteeing the same trusted formulations that have made E45 a beloved staple in households worldwide.